Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CUMBERLAND PHARMACEUTICALS INCCPIX · Entity 6757 | Director · Chairman and CEO · 10% owner | March 18, 2026 | March 20, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CUMBERLAND PHARMACEUTICALS INC
Report date March 18, 2026 · Filed March 20, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.80 · Expires 2036-03-18 | Direct | 568,000 |
Reported balance
After 2026-03-18 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-03-18 · Grant · Acquired 100,000 · Balance 568,000 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 21, 2024 Filed Sep 4, 2024 21:40 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 36 | $1.39 | $50.04 |
DisclosureSEC source: 0001214659-24-016051 · marketforms-66911.xml · nonDerivative · entry 14 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,697,411 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| August 20, 2024 Filed Sep 4, 2024 21:40 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 45 | $1.35 | $60.75 |
DisclosureSEC source: 0001214659-24-016051 · marketforms-66911.xml · nonDerivative · entry 13 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,697,375 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| August 19, 2024 Filed Sep 4, 2024 21:40 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 44 | $1.38 | $60.72 |
DisclosureSEC source: 0001214659-24-016051 · marketforms-66911.xml · nonDerivative · entry 12 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,697,330 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| August 16, 2024 Filed Sep 4, 2024 21:40 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 45 | $1.42 | $63.90 |
DisclosureSEC source: 0001214659-24-016051 · marketforms-66911.xml · nonDerivative · entry 11 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,697,286 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| August 15, 2024 Filed Sep 4, 2024 21:40 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 7 | $1.38 | $9.66 |
DisclosureSEC source: 0001214659-24-016051 · marketforms-66911.xml · nonDerivative · entry 10 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,697,241 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| August 14, 2024 Filed Sep 4, 2024 21:40 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 44 | $1.45 | $63.80 |
DisclosureSEC source: 0001214659-24-016051 · marketforms-66911.xml · nonDerivative · entry 9 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,697,234 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| August 13, 2024 Filed Sep 4, 2024 21:40 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 70 | $1.43 | $100.10 |
DisclosureSEC source: 0001214659-24-016051 · marketforms-66911.xml · nonDerivative · entry 8 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,697,190 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| August 12, 2024 Filed Sep 4, 2024 21:40 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 25 | $1.43 | $35.75 |
DisclosureSEC source: 0001214659-24-016051 · marketforms-66911.xml · nonDerivative · entry 7 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,697,120 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| August 08, 2024 Filed Sep 4, 2024 21:40 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 28 | $1.45 | $40.60 |
DisclosureSEC source: 0001214659-24-016051 · marketforms-66911.xml · nonDerivative · entry 6 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,697,095 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| August 07, 2024 Filed Sep 4, 2024 21:40 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 44 | $1.50 | $66.00 |
DisclosureSEC source: 0001214659-24-016051 · marketforms-66911.xml · nonDerivative · entry 5 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,697,067 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| August 06, 2024 Filed Sep 4, 2024 21:40 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 39 | $1.46 | $56.94 |
DisclosureSEC source: 0001214659-24-016051 · marketforms-66911.xml · nonDerivative · entry 4 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,697,023 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| August 05, 2024 Filed Sep 4, 2024 21:40 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 19 | $1.42 | $26.98 |
DisclosureSEC source: 0001214659-24-016051 · marketforms-66911.xml · nonDerivative · entry 3 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,696,984 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| August 02, 2024 Filed Sep 4, 2024 21:40 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 40 | $1.44 | $57.60 |
DisclosureSEC source: 0001214659-24-016051 · marketforms-66911.xml · nonDerivative · entry 2 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,696,965 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| August 01, 2024 Filed Sep 4, 2024 21:40 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 44 | $1.47 | $64.68 |
DisclosureSEC source: 0001214659-24-016051 · marketforms-66911.xml · nonDerivative · entry 1 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,696,925 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| July 31, 2024 Filed Aug 2, 2024 21:16 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 44 | $1.45 | $63.80 |
DisclosureSEC source: 0001214659-24-013689 · marketforms-66719.xml · nonDerivative · entry 22 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,696,881 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| July 30, 2024 Filed Aug 2, 2024 21:16 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 14 | $1.48 | $20.72 |
DisclosureSEC source: 0001214659-24-013689 · marketforms-66719.xml · nonDerivative · entry 21 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,696,837 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| July 29, 2024 Filed Aug 2, 2024 21:16 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 44 | $1.49 | $65.56 |
DisclosureSEC source: 0001214659-24-013689 · marketforms-66719.xml · nonDerivative · entry 20 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,696,823 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| July 26, 2024 Filed Aug 2, 2024 21:16 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 44 | $1.50 | $66.00 |
DisclosureSEC source: 0001214659-24-013689 · marketforms-66719.xml · nonDerivative · entry 19 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,696,779 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| July 25, 2024 Filed Aug 2, 2024 21:16 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 34 | $1.49 | $50.66 |
DisclosureSEC source: 0001214659-24-013689 · marketforms-66719.xml · nonDerivative · entry 18 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,696,735 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| July 24, 2024 Filed Aug 2, 2024 21:16 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 44 | $1.50 | $66.00 |
DisclosureSEC source: 0001214659-24-013689 · marketforms-66719.xml · nonDerivative · entry 17 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,696,701 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| July 23, 2024 Filed Aug 2, 2024 21:16 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 44 | $1.50 | $66.00 |
DisclosureSEC source: 0001214659-24-013689 · marketforms-66719.xml · nonDerivative · entry 16 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,696,657 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| July 22, 2024 Filed Aug 2, 2024 21:16 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 44 | $1.49 | $65.56 |
DisclosureSEC source: 0001214659-24-013689 · marketforms-66719.xml · nonDerivative · entry 15 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,696,613 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| July 19, 2024 Filed Aug 2, 2024 21:16 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 27 | $1.48 | $39.96 |
DisclosureSEC source: 0001214659-24-013689 · marketforms-66719.xml · nonDerivative · entry 14 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,696,569 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| July 18, 2024 Filed Aug 2, 2024 21:16 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 44 | $1.48 | $65.12 |
DisclosureSEC source: 0001214659-24-013689 · marketforms-66719.xml · nonDerivative · entry 13 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,696,542 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| July 17, 2024 Filed Aug 2, 2024 21:16 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 14 | $1.45 | $20.30 |
DisclosureSEC source: 0001214659-24-013689 · marketforms-66719.xml · nonDerivative · entry 12 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,696,498 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| July 16, 2024 Filed Aug 2, 2024 21:16 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 40 | $1.50 | $60.00 |
DisclosureSEC source: 0001214659-24-013689 · marketforms-66719.xml · nonDerivative · entry 11 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,696,484 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| July 15, 2024 Filed Aug 2, 2024 21:16 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 44 | $1.48 | $65.12 |
DisclosureSEC source: 0001214659-24-013689 · marketforms-66719.xml · nonDerivative · entry 10 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,696,444 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| July 12, 2024 Filed Aug 2, 2024 21:16 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 27 | $1.49 | $40.23 |
DisclosureSEC source: 0001214659-24-013689 · marketforms-66719.xml · nonDerivative · entry 9 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,696,400 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| July 11, 2024 Filed Aug 2, 2024 21:16 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 44 | $1.47 | $64.68 |
DisclosureSEC source: 0001214659-24-013689 · marketforms-66719.xml · nonDerivative · entry 8 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,696,373 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| July 10, 2024 Filed Aug 2, 2024 21:16 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 44 | $1.50 | $66.00 |
DisclosureSEC source: 0001214659-24-013689 · marketforms-66719.xml · nonDerivative · entry 7 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,696,329 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| July 09, 2024 Filed Aug 2, 2024 21:16 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 44 | $1.50 | $66.00 |
DisclosureSEC source: 0001214659-24-013689 · marketforms-66719.xml · nonDerivative · entry 6 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,696,285 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| July 08, 2024 Filed Aug 2, 2024 21:16 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 44 | $1.49 | $65.56 |
DisclosureSEC source: 0001214659-24-013689 · marketforms-66719.xml · nonDerivative · entry 5 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,696,241 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| July 05, 2024 Filed Aug 2, 2024 21:16 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 44 | $1.50 | $66.00 |
DisclosureSEC source: 0001214659-24-013689 · marketforms-66719.xml · nonDerivative · entry 4 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,696,197 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| July 03, 2024 Filed Aug 2, 2024 21:16 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 54 | $1.52 | $82.08 |
DisclosureSEC source: 0001214659-24-013689 · marketforms-66719.xml · nonDerivative · entry 3 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,696,153 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| July 02, 2024 Filed Aug 2, 2024 21:16 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 44 | $1.48 | $65.12 |
DisclosureSEC source: 0001214659-24-013689 · marketforms-66719.xml · nonDerivative · entry 2 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,696,099 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| July 01, 2024 Filed Aug 2, 2024 21:16 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 44 | $1.47 | $64.68 |
DisclosureSEC source: 0001214659-24-013689 · marketforms-66719.xml · nonDerivative · entry 1 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,696,055 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| June 28, 2024 Filed Jul 2, 2024 21:31 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 41 | $1.50 | $61.50 |
DisclosureSEC source: 0001214659-24-011867 · marketforms-66482.xml · nonDerivative · entry 11 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,696,011 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| June 27, 2024 Filed Jul 2, 2024 21:31 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 44 | $1.52 | $66.88 |
DisclosureSEC source: 0001214659-24-011867 · marketforms-66482.xml · nonDerivative · entry 10 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,695,970 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| June 26, 2024 Filed Jul 2, 2024 21:31 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 44 | $1.50 | $66.00 |
DisclosureSEC source: 0001214659-24-011867 · marketforms-66482.xml · nonDerivative · entry 9 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,695,926 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| June 25, 2024 Filed Jul 2, 2024 21:31 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 44 | $1.54 | $67.76 |
DisclosureSEC source: 0001214659-24-011867 · marketforms-66482.xml · nonDerivative · entry 8 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,695,882 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| June 24, 2024 Filed Jul 2, 2024 21:31 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 44 | $1.59 | $69.96 |
DisclosureSEC source: 0001214659-24-011867 · marketforms-66482.xml · nonDerivative · entry 7 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,695,838 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| June 21, 2024 Filed Jul 2, 2024 21:31 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 41 | $1.49 | $61.09 |
DisclosureSEC source: 0001214659-24-011867 · marketforms-66482.xml · nonDerivative · entry 6 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,695,794 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| June 20, 2024 Filed Jul 2, 2024 21:31 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 41 | $1.53 | $62.73 |
DisclosureSEC source: 0001214659-24-011867 · marketforms-66482.xml · nonDerivative · entry 5 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,695,753 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| June 18, 2024 Filed Jul 2, 2024 21:31 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 41 | $1.57 | $64.37 |
DisclosureSEC source: 0001214659-24-011867 · marketforms-66482.xml · nonDerivative · entry 4 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,695,712 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| June 17, 2024 Filed Jul 2, 2024 21:31 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 41 | $1.49 | $61.09 |
DisclosureSEC source: 0001214659-24-011867 · marketforms-66482.xml · nonDerivative · entry 3 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,695,671 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| June 14, 2024 Filed Jul 2, 2024 21:31 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 48 | $1.50 | $72.00 |
DisclosureSEC source: 0001214659-24-011867 · marketforms-66482.xml · nonDerivative · entry 2 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,695,630 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| June 13, 2024 Filed Jul 2, 2024 21:31 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 25 | $1.52 | $38.00 |
DisclosureSEC source: 0001214659-24-011867 · marketforms-66482.xml · nonDerivative · entry 1 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,695,582 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| March 25, 2024 Filed Mar 27, 2024 00:28 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | GrantOptions (right to buy) · Derivative | 100,000 | $0.00 Strike: $1.88 | $0.00 |
DisclosureSEC source: 0001214659-24-005217 · marketforms-65385.xml · derivative · entry 2 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 368,000 Underlying: Stock Option · 100,000 shares Expires 2029-03-25 Read SEC document |
| March 23, 2024 Filed Mar 27, 2024 00:28 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | Tax withholdingCommon Stock | 25,710 | $1.81 | $46,535.10 |
DisclosureSEC source: 0001214659-24-005217 · marketforms-65385.xml · nonDerivative · entry 1 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,695,557 F1 · shares: This transaction represents shares withheld/purchased by the Company to cover the tax withholding obligations for the vesting of shares. Read SEC document |
| December 21, 2023 Filed Dec 28, 2023 22:07 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 87 | $1.70 | $147.90 |
DisclosureSEC source: 0001214659-23-017028 · marketforms-63937.xml · nonDerivative · entry 15 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,721,267 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.